Recursion Pharmaceuticals, Inc. leverages AI to accelerate drug discovery, offering both a licensing platform and an internal drug development pipeline. RXRX faces heavy competition, ongoing operating losses, and significant share dilution, with profitability likely several years away despite strong partnerships and a robust balance sheet. RXRX stock trades at a steep valuation premium, and meaningful revenue from internal drug candidates is not expected until at least 2027.

Plug Power (NASDAQ: PLUG) has become one of the most highly reactive clean-energy stocks in the market. After trading above $4 in early October, the stock experienced a severe 40% drop, plummeting as investors abandoned high-beta renewable companies in response to rising Treasury yields and escalating tariff concerns.

Home Depot‘s third-quarter was mixed with fewer violent storms reaching shore, more anxiety among U.S. consumers, and a housing market that is in a deep funk.

Marvell Technology's expanding optics portfolio powers faster, lower-latency AI networks as demand surges and revenue growth accelerates.

Anthropic to buy $30 billion in Azure capacity in new deal with Microsoft, Nvidia

Beneficient ( BENF ) Q2 2026 Earnings Call November 18, 2025 8:00 AM EST Company Participants Dan Callahan - Director of Communication James Silk - Interim Chief Executive Officer Gregory Ezell - Chief Financial Officer Conference Call Participants Michael Kim - Zacks Small-Cap Research Brendan Michael McCarthy - Sidoti & Company, LLC Presentation Operator Good day, and thank you for standing by. Welcome to the Beneficient Second Quarter Fiscal 2026 Earnings Conference Call.

Microsoft , Nvidia and Anthropic have formed an alliance, with Anthropic committing $30 billion to Azure for its Claude AI models, the companies said on Tuesday.

At one point in early November, the Dow Jones Industrial Average (DJIA) briefly topped 48,000 for the first time ever. At different times in 2025, the NASDAQ and S&P 500 have made new all-time highs (ATHs).

WDC's 114% surge rides soaring AI-fueled storage demand, record high-capacity shipments and rising margins, stirring debate on further upside.

This quarter, we re-established a position in Arista Networks, a leading provider of high-performance networking solutions for data centers, cloud providers, and enterprises. We initiated a starter position in Synopsys after shares sold off following the company's third quarter earnings report and our in-person meeting with management. We exited our CyberArk Software Ltd. position after its acquisition by Palo Alto Networks was announced.

New York, New York--(Newsfile Corp. - November 18, 2025) - If you suffered a loss on your James Hardie Industries plc. (NYSE: JHX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/james-hardie-industries-plc-lawsuit-submission-form?prid=177943&wire=5&utm_campaign=21 or contact Joseph E.

PITTSBURGH , Nov. 18, 2025 /PRNewswire/ -- Today, DICK'S Sporting Goods' (NYSE: DKS) in-house content and production studio, Cookie Jar & A Dream Studios, announced its latest project, Play It Forward: Game On . The unscripted six-episode TV series is set to premiere tomorrow, November 19 at 5:30 p.m.

IREN's 153.1% surge sparks debate as its AI pivot, heavy capex and fierce competition test the sustainability of its rapid growth.

LOCO, OPFI, EIX, SCSC and ZION stand out with attractive EV-to-EBITDA ratios and strong earnings outlooks.

With stocks sliding, volatility spiking and bubble concerns mounting, investors need a defensive game plan. These ETFs can help you navigate the turbulence.

Lockheed (LMT) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Berkshire Hathaway B (BRK.B) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Zacks.com users have recently been watching Organon (OGN) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Intuitive Surgical (ISRG) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Recently, Zacks.com users have been paying close attention to Hims & Hers Health (HIMS). This makes it worthwhile to examine what the stock has in store.